Mecobalamin
Fibromyalgia
Linnaeus UniversityPhase 1/2Dormant
CCC
50/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 37/ 100
- Competitive Position
- 89/ 100
Competitive context
13 Active assets in the Fibromyalgia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Duloxetine Cukurova University | Phase 4 | BBB |
Pregabalin Yung Shin Pharm. Ind. Co., Ltd. | Phase 4 | BB |
PIPERAZINE, 1-(BIS(4-FLUOROPHENYL)METHYL)-4-(3-PHENYL-2-PROPENYL)-, (E)- Taipei Veterans General Hospital, Taiwan | Phase 4 | BB |
LIDOCAINE Peking University Third Hospital | Phase 2 | BB |
Zonisamide University of Pittsburgh | Phase 4 | B |
View all 36 →
Same molecule, other indications
Mecobalamin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →